Current evidence shows that plasma α-MSH levels decrease following severe AIS and other acute brain injuries [10–12] and that exogenous administration of α-MSH following AIS improve stroke outcomes [11]. This evidence concerns the gene STAMBP and androgen insensitivity syndrome.